Acorn Bioventures, based in New York, backs life sciences and healthtech startups at Seed, Series A, and Series B, leading rounds with checks from $100,000 to $10 million.
4 people on the investing team, 2 of them partners who can make the call. Partners are listed first.
Work here and something is wrong? Ask for a correction.

Raising a pre-seed or seed round? We write $1M to $5M first checks and help founders with distribution. A partner reads every deck.
Send your deckOne email when this firm shows new activity. Nothing else.
Acorn Bioventures reports entry at seed, series a, series b.
Acorn Bioventures reports checks of $100K to $10M.
Yes. Acorn Bioventures says it can lead.
Anders Hove (Founder & Partner), Isaac Manke (Partner).
No recent activity since September 2026.
Work at Acorn Bioventures? Claim or correct this profile.